Latest Cancer: Misc. news
FDA Approves Blenrep for Relapsed or Refractory Multiple Myeloma
posted October 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Macrovascular Infiltration May Predict Cancer Mortality
posted October 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
Trend Seen for Improved Recurrence-Free Survival With Pembrolizumab in Merkel Cell Carcinoma
posted October 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Abemaciclib + Endocrine Therapy Improves Survival in HR-Positive, HER2-Negative Early Breast Cancer
posted October 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
PFOA and PFOS Linked to Increased Risk for ER-Negative Breast Cancer
Nonmedical Expense Reimbursement May Make Cancer Trials More Accessible
Obesity Linked to Early-Onset Cancer Risk in Young Adults
Response to Autologous HSCT Durable for Patients With Systemic Sclerosis
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers
Cancer Survivors Have Lower Levels of Physical Activity
Pharmacist-Led Med Review Improves Medication Quality in Older Patients With Cancer